Gene · 5933
Papers2,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Predicting gene compensation in disease with graph embedding techniques. | Artif Intell Med | 2026 | 42632343 | PubTator, text mining | PubMed |
| Fueling or Fighting Cancer? The Thermogenic Paradox of Brown Adipose Tissue. | Curr Obes Rep | 2026 | 41848823 | PubTator, text mining | PubMed |
| Exploiting cellular senescence in hematologic malignancies. | Transl Oncol | 2026 | 41844438 | PubTator, text mining | PubMed |
| Transcriptomics in Venous Leg Ulcers (VLU): A Systematic Review. | Wound Repair Regen | 2026 | 41787822 | PubTator, text mining | PubMed |
| The paradox of cellular senescence in prostate cancer: from tumor suppression to tumor promotion. | Front Oncol | 2026 | 41783438 | PubTator, text mining | PubMed |
| Beyond Oncogenes: Selectively Targeting Whole-Tumor Cell Growth Regulation. | Drug Des Devel Ther | 2026 | 41769264 | PubTator, text mining | PubMed |
| Mechanisms of the Antiproliferative Effects of SIRT6 Inhibition in Melanoma: A Multi-Omics Analysis. | Cancers (Basel) | 2026 | 41749843 | PubTator, text mining | PubMed |
| Intratumoral Androgens and Genetic Variants Driving Therapy Resistance in Prostate Cancer. | Research (Wash D C) | 2026 | 41743623 | PubTator, text mining | PubMed |
| Alterations in AR-FOXA1 signaling in prostate cancer progression and therapeutic resistance. | J Natl Cancer Cent | 2026 | 41738032 | PubTator, text mining | PubMed |
| Targeted therapy for liver cancer: Current status and future directions. | Bioimpacts | 2025 | 41716515 | PubTator, text mining | PubMed |
| Myogenic enhancer snatching promotes adipogenic differentiation during epigenetic reprogramming mediated by lineage-specific transcription factors. | Cell Mol Life Sci | 2025 | 41258103 | PubTator, text mining | PubMed |
| The Tumor Suppressor p53 Downregulates p107 (RBL1) Through p21-RB/E2F Signaling and Tandem E2F Sites. | Int J Mol Sci | 2025 | 41155196 | PubTator, text mining | PubMed |
| USP14 Mediates Molecular Mechanisms Regulating Aortic Valve Stenosis Through Ubiquitination. | J Cell Mol Med | 2025 | 40988122 | PubTator, text mining | PubMed |
| Learning the cellular origins across cancers using single-cell chromatin landscapes. | Nat Commun | 2025 | 40962882 | PubTator, text mining | PubMed |
| Metabolic dysregulation in pulmonary fibrosis: insights into amino acid contributions and therapeutic potential. | Cell Death Discov | 2025 | 40858556 | PubTator, text mining | PubMed |
| High-throughput investigation of cyclin docking interactions reveals the complexity of motif binding determinants. | Nat Commun | 2025 | 40817109 | PubTator, text mining | PubMed |
| Eugenol: An Insight Into the Anticancer Perspective and Pharmacological Aspects. | Food Sci Nutr | 2025 | 40761498 | PubTator, text mining | PubMed |
| Rb substantially compensates for the double loss of p130 and p107 in adult but not embryonic neural stem cell lineages. | Cell Death Dis | 2025 | 40640163 | PubTator, text mining | PubMed |
| Vemurafenib Induces Senescent Phenotype with Increased Adhesion in BRAF Mutant A375 but not in Wild Type BRAF SK-MEL-2 Melanoma Cells. | Adv Pharm Bull | 2025 | 40636307 | PubTator, text mining | PubMed |
Ethanol extract from Ziziphus nummularia stem inhibits MCF-7 breast cancer cell proliferation through TP53 regulating kinase (TP53RK)-mediated p53 activation: In silico and genes expression investigations. | Narra J | 2025 | 40352177 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5933/papers